Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Parenteral fish oil as a pharmacological agent to modulate post-operative immune response: A randomized, double-blind, and controlled clinical trial in patients with gastrointestinal cancer

Full text
Matos de Miranda Torrinhas, Raquel Susana [1, 2] ; Santana, Raquel [1] ; Garcia, Thais [1] ; Cury-Boaventura, Maria Fernanda ; Sales, Maria Mirtes [3] ; Curi, Rui [4] ; Waitzberg, Dan Linetzky [1, 2]
Total Authors: 7
[1] Univ Sao Paulo, Dept Gastroenterol, Med Sch LIM 35, BR-01245903 Sao Paulo - Brazil
[2] Univ Sao Paulo, Food & Nutr Res Ctr NAPAN, BR-01245903 Sao Paulo - Brazil
[3] Univ Sao Paulo, Sect Flow Cytometry, Dept Hematol, Clin Hosp, BR-01245903 Sao Paulo - Brazil
[4] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, BR-01245903 Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: Clinical Nutrition; v. 32, n. 4, p. 503-510, AUG 2013.
Web of Science Citations: 28

Background: Fish oil-based lipid emulsions (FOLEs) have shown post-operative immunological and clinical benefits in parenteral nutrition. Aim: To assess post-operative immune response after short-term pre-operative parenteral infusion of isolated FOLE in gastrointestinal cancer patients. Methods: The patients (n = 63) received pre-operative peripheral infusion (0.2 g fat/kg body weight/d) of FOLE (Omegaven (R)) or control lipid emulsion (MCT/LCT; Lipovenos MCT (R)) for 3 days. Post-operative concentrations of inflammatory mediators, leukocyte functions, surface molecules, infections, and length of intensive care unit (ICU) and hospital stay were measured. Results: FOLE patients had a significant increase of IL-10 levels on day 3, decrease of IL-6 and IL-10 levels on day 6, lower decrease in leukocyte oxidative burst, maintenance of monocyte percentage expressing HLA-DR and CD32, and increase of CD32 neutrophil expression compared to MCT/LCT patients. No changes were observed in the frequency of post-operative infections or length of ICU and hospital stay. Conclusions: Short-term pre-operative infusion of FO alone improves the post-operative immune response of gastrointestinal cancer patients without significantly changing post-operative infections or length of ICU and hospital stay. ID:NCT01218841. (C) 2012 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved. (AU)